Gaia Grow Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Gaia Grow's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals Industry Growth | 23.1% |
Revenue growth rate | n/a |
Return on equity | n/a |
Net Margin | n/a |
Last Earnings Update | 30 Sep 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Gaia Grow makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 22 | 0 | -8 | 2 | 0 |
30 Jun 22 | 0 | -9 | 2 | 0 |
31 Mar 22 | 0 | -7 | 2 | 0 |
31 Dec 21 | 0 | -7 | 2 | 0 |
30 Sep 21 | 0 | -6 | 1 | 0 |
30 Jun 21 | 0 | -5 | 1 | 0 |
31 Mar 21 | 0 | -6 | 1 | 0 |
31 Dec 20 | 0 | -6 | 1 | 0 |
30 Sep 20 | 0 | -2 | 2 | 0 |
30 Jun 20 | 0 | -5 | 2 | 0 |
31 Mar 20 | 0 | -4 | 2 | 0 |
31 Dec 19 | 0 | -3 | 2 | 0 |
Quality Earnings: Insufficient data to determine if GAIA has high quality earnings.
Growing Profit Margin: Insufficient data to determine if GAIA's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if GAIA's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare GAIA's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if GAIA's earnings growth over the past year exceeded the Pharmaceuticals industry average.
Return on Equity
High ROE: GAIA has a negative Return on Equity (0%), as it is currently unprofitable.